This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
This page refreshes automatically every 30 mins. Press F5 to update manually
For a more detailed explanation of Upgrades/Downgrades see Link
Key: (?) = Upgraded, (?) = Downgraded, (-) = Maintained
| Stock | Broker Update |
| Aeorema Communications | Cantor initiates with Buy; TP 90p |
| Anglo American | CIBC ups TP to 1800p from 1550p |
| BAE Systems | Bernstein ups TP 496p from 485p, market perform |
| Barclays | Jefferies cuts TP to 360p from 364p, Buy |
| Coca Cola HBC AG | SocGen cuts TP to 1340P from 1520P, sell |
| DCC | JP Morgan cuts TP to 2,997p from 3,074p, overweight |
| Euromoney Institutional Investor | UBS ups TP to 1500p from 1350p, Buy |
| Evraz | Barclays cuts TP to 75p from 122p, underweight |
| Firstgroup | JP Morgan ups TP to 165p from 150p, overweight |
| Go-Ahead Group | JP Morgan ups TP to 2100p from 1800p, overweight |
| Hammerson | Jefferies ups TP to 554p from 540p, Hold |
| Hammerson | Morgan Stanley ups TP to 570p from 560p, Equalweight |
| Hutchison China MediTech | Panmure ups TP to 750p from 725p, Buy |
| Polymetal International | Barclays ups TP to 550p from 500p, underweight |
| Polyus Gold International | Barclays ups TP to 160p from 150p, underweight |
| Quindell | Canaccord Genuity ups TP to 87p from 75p, Buy |
| Rolls-Royce | Citigroup downgrades to neutral from Buy; TP to 1070p from 1280p |
| Shire | Jefferies ups TP to $170 from $165, Buy |
| Stagecoach Group | JP Morgan ups TP to 410p from 390p, overweight |
| Tate & Lyle | Berenberg cuts TP to 775p from 900p, Buy |
| Tullow Oil | Bernstein cuts TP to 1450p from 1600p, outperform |
| WM Morrison Supermarkets | JP Morgan cuts TP to 190p from 210p, underweight |
| Source: Reuters News, AlphaTerminal, Dow Jones Newswires | |
Source: Bloomberg, Reuters News, AlphaTerminal, Dow Jones Newswires
T111his research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research